Training & Support Included
Evidence-Based Protocols
Australian Support Team
Warranty 2 years.
Clinical Mechanism:
The PRF technique (Choukroun et al. 2001) involves centrifugation of whole blood without anticoagulants. This process yields a fibrin clot rich in platelets and leukocytes, acting as a natural reservoir of growth factors (VEGF, PDGF, TGF-β). These are gradually released, accelerating bone and soft tissue healing in surgical sites.
Indications for Use in Aesthetics:
PRF may be prepared and applied by registered health professionals for use in:
Autologous injectable protocols as part of aesthetic procedures performed in clinical practice
Supporting soft tissue integration following minimally invasive interventions
Adjunctive use in procedures involving dermal and subdermal tissue application
Preparation of autologous biomaterial for clinical use in aesthetic medicine
What is PRF?
Platelet-Rich Fibrin (PRF) is an autologous platelet concentrate derived from the patient’s own blood. PRF contains platelets, fibrin, and growth factors and is used in clinical procedures to support tissue healing and regeneration. Blood is collected into the tube and centrifuged without anticoagulants, producing a fibrin-rich layer for clinical application.
Regulatory Status:
ARTG-listed Class IIa. Official Process for PRF® product, developed by Dr. Choukroun creator of the Process for PRF® (Platelet Rich Fibrin) technique (A-PRF, i-PRF, & S-PRF).
Is training included?
Yes. All PRF Systems include a complementary in-service session. Users also receive access to PRF webinars conducted by Dr. Joseph Choukroun.
Are these products TGA listed?
Yes. All components of the PRF System – including tubes, centrifuges, instruments, and blood collection devices – are ARTG-listed Class IIa medical devices.